TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive Cancer Groups Fear Clinical Trials Coverage Will Not Be Implemented Across Exchanges July 3, 2013